"Handshake across the Himalayas"
India and China will study new ways to ease tensions along their ill-defined border, Chinese Premier Li Keqiang said on Monday in his first foreign trip since taking office, which comes just weeks after a military stand-off between the Asian giants in the Himalayas. Full Article | Slideshow
Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade. Full Coverage
MARKET EYE-India's Cipla surges to record high on earnings
* Shares in Cipla gains as much as 4.06 percent to a record high after the drug maker reported a bigger-than-expected 62 percent surge in July-September net profit. * Despite the surge in share prices, Citigroup says on Tuesday it remains cautious, saying the earnings surprise were mainly driven by the generic version of anti-depressant drug Lexapro, whose exclusivity would tail off in the second half of the fiscal year. * Cipla had earlier given a revenue guidance of up to 12 percent for the current fiscal year, but Citigroup says the company management has now revised its topline growth to 15 percent or above in FY13. * Citigroup adds positives such as better product mix and upside from a weaker rupee appeared factored into estimates and valuations. * The bank raised its target price to 390 rupees from 360 rupees, but retained its 'neutral' rating. * Cipla shares advanced 2.8 percent to 390.90 rupees as of 0437 GMT (firstname.lastname@example.org)
- Tweet this
- Share this
- Digg this